Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel

Drug Development and Industrial Pharmacy

Volumn 37, Issue 5, 2011, Pages 597-605

  Liang, Huijun ^a   Yang, Qiuxia ^a   Deng, Li ^a   Lu, Jianzhong ^b   Chen, Jianming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

antitumor activity; hemolysis; Mixed micelles; paclitaxel; pharmacokinetics; stability

Indexed keywords

PACLITAXEL; PHOSPHOLIPID; POLYSORBATE 80; SOYBEAN PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICELLE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; HELA CELLS; HEMOLYSIS; HUMANS; INJECTIONS, INTRAVENOUS; MICELLES; PACLITAXEL; PARTICLE SIZE; PHOSPHOLIPIDS; POLYSORBATES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEAN OIL;

EID: 79953773205     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.533276     Document Type: Article

References (52)

1. Aguiar J, Carpena P, Molina-Bolä-var JA, Ruiz CC. (2003). On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J Colloid Interface Sci 258:116-122. (Pubitemid 36228364)
2. Alkan-Onyuksel H, Ramakrishnan S, Chai HB, Pezzuto JM. (1994). A mixed micellar formulation suitable for the parenteral administration of Taxol. Pharm Res 11:206-212. (Pubitemid 24076213)
3. Bakshi MS, Singh J, Kaur G. (2005). Antagonistic mixing behavior of cationic gemini surfactants and triblock polymers in mixed micelles. J Colloid Interface Sci 285:403-412. (Pubitemid 41350453)
4. Cevc G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675-711. (Pubitemid 38326939)
5. Cevc G, Gebauer D. (2003). Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J 84:1010-1024. (Pubitemid 36133426)
6. Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. (2006). Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 315:148-157. (Pubitemid 43674120)
7. Danhier F, Lecouturier N, Vroman B, Jéräme C, Marchand-Brynaert J, Feron O, Préat V. (2009). Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 133:11-17.
8. Fadda M, Baroli BM, Maccioni AM, Sinico C, Valent D, Alhaiqu F. (1998). Phospholipid-detergent systems: effects of polysorbates on the release of liposomal caffeine. II Farmaco 53:650-654. (Pubitemid 29139834)
9. Fjällskog ML, Frii L, Bergh J. (1993). Is Cremophor EL, solvent for paclitaxel, cytotoxic? Lancet 342:873.
10. Gabizon AA. (1995). Liposome circulation time and tumor targeting: implications for cancer chemotherapy. Adv Drug Deliv Rev 16:285-294.
11. Gao ZG, Fain HD, Rapoport N. (2005). Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release 102:203-222. (Pubitemid 40093786)
12. Gao ZG, Lukyanov AN, Singhal A, Torchilin VP. (2002). Diacyl lipid polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Letters 2:979-982.
13. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109:169-188. (Pubitemid 41742123)
14. Gelderblom H, Verweij J, Nooter K, Sparreboom A. (2001). Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590-1598. (Pubitemid 32778603)
15. Haque ME, Das AR, Moulik SP. (1999). Mixed micelles of sodium deoxycholate and polyoxyethylene sorbitan monooleate (Tween 80). J Colloid Interface Sci 217:1-7. (Pubitemid 29395066)
16. Huh KM, Lee SC, Cho YW, Lee J, Jeong JH, Park K. (2005). Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 101:59-68. (Pubitemid 39600972)
17. Khatua D, Gupta A, Dey J. (2006). Characterization of micelle formation of dodecyldimethyl-N-2-phenoxyethylammonium bromide in aqueous solution. J Colloid Interface Sci 298:451-456.
18. Kollipara S, Bende G, Movva S, Saha R. (2010). Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel. Drug Dev Ind Pharm 36:1377-1387.
19. Koo OM, Rubinstein I, Onyuksel H. (2005). Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomedicine 1:77-84. (Pubitemid 43963604)
20. Lee CS, Kim C, Chan Kwon I, Chung H, Young Jeong S. (2003). Polymeric micelles of poly(2-ethyl-2-oxazoline)-blockpoly( epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 89:437-446. (Pubitemid 36555903)
21. Leng J, Egelhaaf SU, Cates ME. (2003). Kinetics of the micelle-tovesicle transition: aqueous lecithin-bile salt mixtures. Biophys J 85:1624-1646. (Pubitemid 37055451)
22. Li L, Tan YB. (2008). Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE. J Colloid Interface Sci 317:326-331. (Pubitemid 350088816)
23. Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA. (1983). Role of surface-active phospholipids in gastric cytoprotection. Science 219:1327-1329. (Pubitemid 13109164)
24. Liggins RT, Burt HM. (2002). Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 54:191-202. (Pubitemid 34230441)
25. Lukyanov AN, Torchilin VP. (2004). Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56:1273-1289. (Pubitemid 38510474)
26. Lundberg BB, Risovic V, Ramaswamy M, Wasan KM. (2003). A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Release 86:93-100. (Pubitemid 35461976)
27. Maeda H, Sawa T, Konno T. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47-61. (Pubitemid 32727608)
28. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271-284. (Pubitemid 30122932)
29. Martin GP, Marriott C. (1981). Membrane damage by bile salts: the protective function of phospholipids. J Pharm Pharmacol 33:754-759. (Pubitemid 12181359)
30. Miyahara M, Kawasaki H, Garamus VM, Nemoto N, Kakehashi R, Tanaka S, Annaka M, Maeda H. (2004). Micelle-vesicle transition of oleyldimethylamine oxide in water. Colloids Surf B Biointerfaces 38:131-138. (Pubitemid 39473327)
31. Nishiyama N, Kataoka K. (2001). Preparation and characterization of size-controlled polymeric micelle containing cisdichlorodiammineplatinum( II) in the core. J Control Release 74:83-94. (Pubitemid 32727612)
32. Ollivon M, Lesieur S, Grabielle-Madelmont C, Paternostre M. (2000). Vesicle reconstitution from lipid-detergent mixed micelles. Biochim Biophys Acta 1508:34-50.
33. Rijcken CJ, Snel CJ, Schiffelers RM, van Nostrum CF, Hennink WE. (2007). Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials 28:5581-5593. (Pubitemid 47599643)
34. Sautou-Miranda V, Brigas F, Vanheerswynghels S, Chopineau J. (1999). Compatibility of paclitaxel in 5% glucose solution with ECOFLAC low-density polyethylene containers-stability under different storage conditions. Int J Pharm 178:77-82. (Pubitemid 29074409)
35. Sezgin Z, Yüksel N, Baykara T. (2006). Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 64:261-268. (Pubitemid 44585209)
36. Simões SI, Marques CM, Cruz ME, Cevc G, Martins MB. (2004). The effect of cholate on solubilisation and permeability of simple and protein-loaded phosphatidylcholine/sodium cholate mixed aggregates designed to mediate transdermal delivery of macromolecules. Eur J Pharm Biopharm 58:509-519. (Pubitemid 39302554)
37. Simões SI, Tapadas JM, Marques CM, Cruz ME, Martins MB, Cevc G. (2005). Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. Eur J Pharm Sci 26:307-317. (Pubitemid 41282799)
38. Singla AK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm 235:179-192. (Pubitemid 34185449)
39. Stuart MC, Boekema EJ. (2007). Two distinct mechanisms of vesicleto- micelle and micelle-to-vesicle transition are mediated by the packing parameter of phospholipid-detergent systems. Biochim Biophys Acta 1768:2681-2689. (Pubitemid 350060864)
40. Szebeni J, Muggia FM, Alving CR. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90:300-306. (Pubitemid 28182386)
41. Sznitowska M, Klunder M, Placzek M. (2008). Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin. Chem Pharm Bull 56:70-74.
42. van Tellingen O, Beijnen JH, Verweij J, Scherrenburg EJ, Nooijen WJ, Sparreboom A. (1999). Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin Cancer Res 5:2918-2924. (Pubitemid 29493971)
43. van Zuylen L, Verweij J, Sparreboom A. (2001). Role of formulation vehicles in taxane pharmacology. Invest New Drugs 19:125-141. (Pubitemid 32423718)
44. Wang J, Mongayt D, Torchilin VP. (2005). Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target 13:73-80. (Pubitemid 40309464)
45. Wang W, Wang YJ, Wang DQ. (2008). Dual effects of Tween 80 on protein stability. Int J Pharm 347:31-38. (Pubitemid 350180316)
46. Wu L, Tang C, Yin C. (2010). Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm 36:439-448.
47. Yang TF, Chen CN, Chen MC, Lai CH, Liang HF, Sung HW. (2007). Shell-crosslinked Pluronic L121 micelles as a drug delivery vehicle. Biomaterials 28:725-734.
48. Yi Y, Yoon HJ, Kim BO, Shim M, Kim SO, Hwang SJ, Seo MH. (2007). A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics. J Control Release 117:59-67. (Pubitemid 46161866)
49. Yin H, Lei S, Zhu S, Huang J, Ye J. (2006). Micelle-to-vesicle transition induced by organic additives in cationic surfactant systems. Chemistry 12:2825-2835.
50. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752-3756.
51. Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H. (2008). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29:1233-1241.
52. Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I. (2005). Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177-187. (Pubitemid 39573451)